Chief Executive Officer
Vivek Ramaswamy is founder and Chief Executive Officer of Roivant Sciences. The Roivant family of companies includes multiple wholly owned or majority-owned biopharmaceutical subsidiaries, each focused on a different disease area. Roivant has 16 drugs in its collective pipeline and has raised more than $2.5 billion in capital to date to fund clinical programs and pursue adjacent business opportunities in healthcare. Prior to founding Roivant, Mr. Ramaswamy was an investor in the biotechnology sector. He received an A.B. summa cum laude in biology from Harvard College and a J.D. from Yale Law School.